ATAI Life Sciences
ATAI
ATAI
88 hedge funds and large institutions have $24.6M invested in ATAI Life Sciences in 2024 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 15 increasing their positions, 21 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
2.45% less ownership
Funds ownership: 9.95% → 7.5% (-2.5%)
29% less repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 21
Holders
88
Holding in Top 10
1
Calls
$1.18M
Puts
$953K
Top Buyers
| 1 | +$2.87M | |
| 2 | +$283K | |
| 3 | +$212K | |
| 4 |
Walleye Capital
New York
|
+$202K |
| 5 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$164K |
Top Sellers
| 1 | -$7.14M | |
| 2 | -$938K | |
| 3 | -$879K | |
| 4 |
CAM
Cresset Asset Management
Chicago,
Illinois
|
-$591K |
| 5 |
JPMorgan Chase & Co
New York
|
-$554K |